Inventiva IVA
NASDAQ IVA
$4.01 +0.06 (+1.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Inventiva (IVA) Price to Sales (2021)

Updated

Inventiva's (IVA) Price to Sales came in at 172.19 for FY2025, compared with 13.02 in FY2024.

Analysis

Inventiva (IVA) Price to Sales (2021) Analysis & Trends

Since FY2020, Inventiva has reported Price to Sales for 6 years.

  • The FY2025 figure stands as the highest annual Price to Sales since FY2020.
  • Business Quant data shows IVA's Price to Sales at 13.02 in FY2024 (+3.9%), 12.53 in FY2023 (-17.2%), 15.12 in FY2022 (-86.6%) and 112.50 in FY2021 (-91.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Inventiva 763.29 Mn 38.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1,526.90
API Access

Inventiva Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=IVA&period=max&api_key=YOUR_API_KEY